[data-jobs-progressive-shell] > [data-jobs-server-fallback] { display: block !important; } [data-jobs-progressive-shell] > [data-jobs-client-shell] { display: none !important; }

Marketing jobs

9 marketing jobs

8 days ago

Global Alzheimer Disease Marketing Lead /Atlanta

UCB

Atlanta, GA (Hybrid)Permanent$184K/yr – $242K/yr

8 days ago

Global Alzheimer Disease Marketing Lead /Boston

UCB

Boston, MA (Hybrid)$184K/yr – $242K/yr

8 days ago

Global Alzheimer Disease Marketing Lead /Atlanta

UCB

Atlanta, GA (Hybrid)$184K/yr – $242K/yr

8 days ago

Global Alzheimer Disease Marketing Lead

UCB

Raleigh, NC (Hybrid)$184K/yr – $242K/yr

5 weeks ago

Key Account Manager / San Jose

UCB

San Jose, CA (Unknown)$144K/yr – $189K/yr

3 months ago

Peer-to-Peer Marketing Lead Dermatology

UCB

Atlanta, GA (Hybrid)Other$164K/yr – $215K/yr

4 months ago

Digital Technology Lead, Omnichannel Marketing

UCB

Atlanta, GA (Hybrid)Permanent$148K/yr – $195K/yr

4 months ago

Peer-to-Peer Marketing Lead Dermatology

UCB

Atlanta, GA (Hybrid)Full time$164K/yr – $215K/yr

4 months ago

Peer-to-Peer Marketing Lead Dermatology

UCB

Atlanta, GA (Hybrid)Permanent$164K/yr – $215K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

9 jobs

Global Alzheimer Disease Marketing Lead /Atlanta

UCB

Atlanta, GA (Hybrid)

$184K/yr - $242K/yrIn-housePermanentDirector/executive

8 days ago

Global Alzheimer Disease Marketing Lead /Boston

UCB

Boston, MA (Hybrid)

$184K/yr - $242K/yrIn-houseDirector/executive10+ years exp.

8 days ago

Global Alzheimer Disease Marketing Lead /Atlanta

UCB

Atlanta, GA (Hybrid)

$184K/yr - $242K/yrIn-houseDirector/executive10+ years exp.

8 days ago

Global Alzheimer Disease Marketing Lead

UCB

Raleigh, NC (Hybrid)

$184K/yr - $242K/yrIn-houseDirector/executive10+ years exp.

8 days ago

Key Account Manager / San Jose

UCB

San Jose, CA (Unknown)

$144K/yr - $189K/yrIn-houseSenior level7+ years exp.

5 weeks ago

Peer-to-Peer Marketing Lead Dermatology

UCB

Atlanta, GA (Hybrid)

$164K/yr - $215K/yrIn-houseOtherSenior level7+ years exp.

3 months ago

Digital Technology Lead, Omnichannel Marketing

UCB

Atlanta, GA (Hybrid)

$148K/yr - $195K/yrIn-housePermanentSenior level10+ years exp.

4 months ago

Peer-to-Peer Marketing Lead Dermatology

UCB

Atlanta, GA (Hybrid)

$164K/yr - $215K/yrIn-houseFull-timeSenior level7+ years exp.

4 months ago

Peer-to-Peer Marketing Lead Dermatology

UCB

Atlanta, GA (Hybrid)

$164K/yr - $215K/yrIn-housePermanentSenior level7+ years exp.

4 months ago

UCB

Global Alzheimer Disease Marketing Lead /Atlanta

Atlanta, GA (Hybrid)

$184K/yr – $242K/yrDirector/ExecutivePermanent

Posted 8 days ago

Job Summary

The role owns shaping Alzheimer's asset strategy by leading cross‑functional commercial decision making, defining patient value propositions, and building market assessments and adoption plans across diagnosis, biomarkers, and care pathways.

Own global commercialization strategy and market development priorities
Synthesize external stakeholder insights into asset recommendations

Job Description

Responsibilities

Build UCB's Alzheimer's disease knowledge and translate patient, caregiver, stakeholder, diagnostic, access, and competitive insights into asset choices.
Lead the global cross-functional forum for learning, collaboration and commercial decision making.
Develop the patient population and indication vision, value proposition, positioning, and commercialization strategy.
Define the market-development priorities required to support future adoption, including diagnosis, biomarkers, referral and treatment pathways, healthcare infrastructure, and care delivery.
Develop market assessments, forecasts, business cases, and commercialization scenarios, including key assumptions, uncertainties, and capability needs.
Support evaluation of development and partnering scenarios through commercial assessment of strategic options, assumptions, opportunities, and risks.
Bring external stakeholder perspectives into asset decisions and translate the work into clear recommendations for the Asset team.

Requirements

Bachelor’s degree.
10+ years of pharmaceutical strategy, marketing, or commercialization experience.
2+ years direct Alzheimer’s disease or dementia experience.
2+ years experience supporting a development-stage, post-proof-of-concept, or pre-launch asset.

Preferred

Experience developing market assessments, forecasts, scenarios, or business cases
Strong understanding of Alzheimer’s diagnosis, biomarkers, stakeholders, and treatment pathways.
U.S. pharmaceutical commercialization experience.
Global pharmaceutical strategy or commercialization experience.
Experience supporting partnered or co-development assets.
Strong business judgment and ability to synthesize incomplete information.
Demonstrated success leading through influence across functions and geographies.

UCB

4.0 Glassdoor

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine.We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives.From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future.We're inspired by patients, driven by science.

Founded in 1928

Brussels, Brussels Region, BEL

14K employees (686 in marketing)

www.ucb.com

82% recommend to a friend

90% CEO approval

Salaries

Posted range

$184K/yr – $242K/yr

Taken straight from the job posting.

See all UCB salaries

Marketing Team

Marketing Team Size

568 (4% of company)

Median Career Experience

18 years

Median Tenure

5 years

Marketing Roles Posted (Last 30 Days)

People

Marketing Leadership

Marcus Krause

Head of Marketing - Rheumatology

At the company for 18 years 5 months

Caroline Hawkins

Head of Mito Disease/Tk2d Marketing, US

At the company for 3 years 4 months

Jennifer Tolley

Head of Omnichannel and Digital Marketing

At the company for 3 years 4 months

Bipan Singh

Head of Marketing- Rare Syndrome (Developmental Epileptic Encephalopathies)

At the company for 7 years 9 months

Funding

Total Funding

$201.8M

Last Raise

$101M

Post IPO Equity, 4 years ago

Funding History

May 2022
Post IPO Equity • $101M
May 2015
Post IPO Equity • $787.6K
Dec 2009
Post IPO Equity • $100M

Traffic Signals

Monthly Visitors

154.3K

Traffic Source Mix

52%

Direct

34.6%

Referral

8.4%

Social

Paid

0.9%

Headcount Trend

Current headcount: ~14.3K

Recent News

Grâce à UCB et argenx, le Bel 20 passe le cap des 5 000 points pour la première fois de son histoire

Oct 16, 2025 • La Libre.be

L’action UCB a quadruplé en deux ans, a-t-elle encore du jus?

Oct 14, 2025 • L'Echo

Bourse: mais où s’arrêtera UCB ?

Oct 8, 2025 • Trends-Tendances

Links

www.ucb.com

X (Twitter)

Crunchbase

This role is listed on SalaryGuide for informational purposes. SalaryGuide is not the employer, recruitment agency, or hiring representative for this position. Hiring decisions and the application process are managed by the employer. SalaryGuide will never ask candidates to pay to apply for a job or request bank details or identification documents as part of an application.

Responsibilities

Build UCB's Alzheimer's disease knowledge and translate patient, caregiver, stakeholder, diagnostic, access, and competitive insights into asset choices.
Lead the global cross-functional forum for learning, collaboration and commercial decision making.
Develop the patient population and indication vision, value proposition, positioning, and commercialization strategy.
Define the market-development priorities required to support future adoption, including diagnosis, biomarkers, referral and treatment pathways, healthcare infrastructure, and care delivery.
Develop market assessments, forecasts, business cases, and commercialization scenarios, including key assumptions, uncertainties, and capability needs.
Support evaluation of development and partnering scenarios through commercial assessment of strategic options, assumptions, opportunities, and risks.
Bring external stakeholder perspectives into asset decisions and translate the work into clear recommendations for the Asset team.

Requirements

Bachelor’s degree.
10+ years of pharmaceutical strategy, marketing, or commercialization experience.
2+ years direct Alzheimer’s disease or dementia experience.
2+ years experience supporting a development-stage, post-proof-of-concept, or pre-launch asset.

Preferred

Experience developing market assessments, forecasts, scenarios, or business cases
Strong understanding of Alzheimer’s diagnosis, biomarkers, stakeholders, and treatment pathways.
U.S. pharmaceutical commercialization experience.
Global pharmaceutical strategy or commercialization experience.
Experience supporting partnered or co-development assets.
Strong business judgment and ability to synthesize incomplete information.
Demonstrated success leading through influence across functions and geographies.